510(k) Report

510(k) · Cleared

Cleared

Thrombix 3X3 Hemostatic Pad

K053054510(k) SpecialCleared Nov 23, 200523-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Vascular Solutions, Inc. · QSX Hemostatic Wound Dressing With Thrombin Or Other Biologics

Cleared on Nov 23, 2005 as substantially equivalent to K040510 (Vascular Solutions, Inc., 2004) and 1 other predicate after a 23-day review. Its family tree reaches back 5 generations to 1990.

Decided
Nov 23, 2005
Review
23 days
Class
Class U
Product code
QSX
Recalls
None
Predicates
2

Its longest line of descent runs back 5 generations to K896068 (1990). 7 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK896068 Tipstop (TM)Gambro-Hospal, Inc. · 1990
  2. 4 generations backK982818 Hospal TipstopGambro Healthcare · 1998
  3. 3 generations backK012293 Vascular Solutions Duett Flowable HemostatVascular Solutions, Inc. · 2002
  4. 2 generations backK030836 D-Stat-Dry Hemostatic Bandage; D-Stat Radial Hemostatic BandageVascular Solutions, Inc. · 2003 · Recalled
  5. 1 generation backK050511 Thrombigel Thrombin/Gelatin Foam HemostatVascular Solutions, Inc. · 2005
  6. This deviceK053054 Thrombix 3X3 Hemostatic PadVascular Solutions, Inc. · 2005
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K896068Tipstop (TM)Gambro-Hospal, Inc.1990—
−4K982818Hospal TipstopGambro Healthcare1998—
−3K012293Vascular Solutions Duett Flowable HemostatVascular Solutions, Inc.2002—
−2K030836D-Stat-Dry Hemostatic Bandage; D-Stat Radial Hemostatic BandageVascular Solutions, Inc.20033
−1K050511Thrombigel Thrombin/Gelatin Foam HemostatVascular Solutions, Inc.2005—
0 (this device)K053054Thrombix 3X3 Hemostatic PadVascular Solutions, Inc.2005—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
200410
FIG. 1 — Lineage of K053054, 1990–2005Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QSX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QSX device

  1. #1 K200720 D-Stat Radial Topical Hemostatscore 0.8 · 5 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K040510Vascular Solutions D-Stat Dry 3X3 Hemostatic Pad
Summary page 5
…pad after addition of up to 10 mls of saline. Predicate Devices: D-Stat Dry 3x3 hemostatic pad (K040510) ThrombiGel thrombin/gelatin foam hemostat (K050511) Conclusions: Th…
Vascular Solutions, Inc.2004—
*K050511Thrombigel Thrombin/Gelatin Foam Hemostat
Summary page 5
…icate Devices: D-Stat Dry 3x3 hemostatic pad (K040510) ThrombiGel thrombin/gelatin foam hemostat (K050511) Conclusions: The Thrombix 3x3 hemostatic pad is substantially equiv…
Vascular Solutions, Inc.2005—

Also cleared against K040510: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 15 years and passes through 3 companies; a new generation was cleared every 1.7 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • 1 other device also cites its predicate K040510.

How does its category compare?

All QSX devices

QSX Hemostatic Wound Dressing With Thrombin Or Other Biologics: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · QSX

1in 2020

2007: 42008: 12009: 12011: 12020: 1
2007high 4 (2007) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QSX

56in 2007

2007: 56 days median
2007high 56 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QSX

No recall names QSX since 2007.

Adverse event reports per year · QSX

No MAUDE report names QSX since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200745600
20081—00
20091—00
20100—00
20111—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20201—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The Thrombix 3X3 pad is applied topically and is indicated as a trauma dressing for temporary control of moderate to severely bleeding wounds and for the control of surface bleeding from vascular access sites and percutaneous catheters or tubes.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K053054: Thrombix 3X3 Hemostatic Pad.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K053054

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026